Click for our Prostate Cancer Website En Espanol
Contact & Location

CyberKnife Center of Miami Blog

A Helpful Resource for Our Patients rss

Tumor Patients Have More Treatment Options Then Ever Before!

by Bevon Findley (SU)
Help us spread the word about CyberKnife Miami. Too many people still have no idea how this radio-surgery technology is saving the lives of patients with cancerous and non-cancerous tumors. Tell everyone you know. It could make a major difference in the outcome of their treatment or a loved one’s. Click on the link below and see how and why CyberKnife is giving patients more treatment options.

CyberKnife Nonsurgical Option for Spine Tumors

by Bevon Findley (SU)
CyberKnife Miami – The Beam of Life – has long been offering radio surgery to prolong lives and manage spine tumors and we are thrilled to see others are following suit as seen by the following news story on the PRWEB.

NewCyberKnife Study Shows SBRT 
Effective in Treatment of Prostate Cancer The Results May Offer Hope For Patients Unable To Undergo Surgery

by Bevon Findley (SU)

Philadelphia CyberKnife radiation oncologist Dr. Rachelle Lanciano co-wrote newly published research on stereotactic body radiation therapy for prostate cancer treatment.

Our results are consistent or better than other studies of radiation or surgery for prostate cancer with five year follow up reported for patients treated with SBRT.

Bye Bye Biopsy! Chemicals Diagnose Cancer

by Bevon Findley (SU)

FT. LAUDERDALE, Fla. (Ivanhoe Newswire) — It’s believed close to 70 thousand Americans will be diagnosed with a cancerous or non-cancerous brain tumor this year. Even if they’re removed, there’s a chance the tumors could come back. Now, doctors are using a new way to figure out if a dangerous tumor is regrowing or if something else is going on in the brain.

CyberKnife Therapy Offers Benefits For Recurring GYN Cancers

by Bevon Findley (SU)

From: Ob.Gyn. News Digital Network
Robotic Cyberknife radiation therapy will likely expand the treatment options for patients whose gynecologic malignancies recur, researchers reported at the annual meeting of the Society of Gynecologic Oncologists.

A total of 50 patients with recurrent gynecologic (mainly ovarian and endometrial) cancers underwent Cyberknife treatment, which allows targeting of high doses of radiation to the tumor while largely sparing adjacent healthy tissue. In this case, patients received an 8-Gy treatment on each of 3 consecutive days.